09 Mar 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—March 9, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the start of enrollment in the LIFT Home Study. The trial is designed to study the safety and performance of ARCEX Therapy when used in the home.
07 Feb 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—February 7, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the publication of STIMO-BRIDGE Study results in Nature Medicine. The study highlights the use of ONWARD’s technology to enable people with even the most severe forms of spinal cord injury to walk, stand, cycle, and swim again.
19 Jan 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—January 19, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces that its senior leadership will participate at the upcoming Degroof Petercam Healthcare Conference. Dave Marver, Chief Executive Officer, will be available for one-on-one virtual meetings on January 26, 2022.
06 Jan 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—January 6, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces the company and its partners have been awarded nine new patents, seven of them in collaboration with leading neuroscience research laboratories at Caltech, UCLA, EPFL, and University of Louisville.

Upcoming Events

Recent Presentations